CompletedEarly Phase 1

Rhomboid Intercostal and Sub-serratus Block

Egypt60 participantsStarted 2021-06-01

Plain-language summary

The rhomboid intercostal block (RIB) can provide good analgesia effects after thoracic surgery . The ultrasound-guided RIB is novel analgesic techniques recently described by Elsharkawy et al. . Additionally, the RISS block anesthetizes the lateral cutaneous branches of the thoracic intercostal nerves and can be used in multiple clinical settings for chest wall and upper abdominal analgesia. However, the analgesic effects of the RISS block after breast surgery have not been analyzed through a randomized-controlled trial.

Who can participate

Age range18 Years – 40 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria Adult patients between 18-50 years. ASA physical status I and II Male gender Exclusion criteria Patient refusal Contraindications to regional anesthesia Known allergy to local anesthetics Bleeding disorders Use of any anti-coagulants Inability to provide informed consent ASA III-IV \-

What they're measuring

morphine consumption

Timeframe: 24 hours

Trial details

NCT IDNCT04859803

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-09-25

View on ClinicalTrials.gov More Rhomboid Intercostal Block trials